COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections (LRTIs) in infants worldwide. The global direct medical cost associated with RSV LRTIs reaches billions of dollars, with the highest burden in low-middle-income countries. Many efforts have been devoted...
Saved in:
Main Authors: | Andrea Gastaldi (Author), Daniele Donà (Author), Elisa Barbieri (Author), Carlo Giaquinto (Author), Louis J. Bont (Author), Eugenio Baraldi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Respiratory syncytial virus (RSV) disease - new data needed to guide future policy
by: Louis Bont, et al.
Published: (2015) -
Seasonal immunisation against respiratory syncytial virus disease
by: Koos Korsten, et al.
Published: (2017) -
Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
by: Xiao Li, et al.
Published: (2024) -
The new reporting obligation for Respiratory Syncytial Virus (RSV) in Germany - a critical view
by: Heudorf, Ursel, et al.
Published: (2024) -
Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants
by: Lu Wang, et al.
Published: (2021)